Lataa...
Genomic profile, smoking, and response to anti-PD-1 therapy in non-small cell lung carcinoma
The recent successes of immune checkpoint therapies have established a new era for the treatment of patients with cancer, yet the predictors of response remain largely undetermined. We recently demonstrated that the genomic landscape of lung cancers substantially influences the response to programme...
Tallennettuna:
| Julkaisussa: | Mol Cell Oncol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4845184/ https://ncbi.nlm.nih.gov/pubmed/27308563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2015.1048929 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|